» Articles » PMID: 27903541

Lifelong Physical Activity Regardless of Dose Is Not Associated With Myocardial Fibrosis

Abstract

Background: Recent reports have suggested that long-term, intensive physical training may be associated with adverse cardiovascular effects, including the development of myocardial fibrosis. However, the dose-response association of different levels of lifelong physical activity on myocardial fibrosis has not been evaluated.

Methods And Results: Seniors free of major chronic illnesses were recruited from predefined populations based on the consistent documentation of stable physical activity over >25 years and were classified into 4 groups by the number of sessions/week of aerobic activities ≥30 minutes: sedentary (group 1), <2 sessions; casual (group 2), 2 to 3 sessions; committed (group 3), 4 to 5 sessions; and Masters athletes (group 4), 6 to 7 sessions plus regular competitions. All subjects underwent cardiopulmonary exercise testing and cardiac magnetic resonance imaging, including late gadolinium enhancement assessment of fibrosis. Ninety-two subjects (mean age 69 years, 27% women) were enrolled. No significant differences in age or sex were seen between groups. Median peak oxygen uptake was 25, 26, 32, and 40 mL/kg/min for groups 1, 2, 3, and 4, respectively. Cardiac magnetic resonance imaging demonstrated increasing left ventricular end-diastolic volumes, end-systolic volumes, stroke volumes, and masses with increasing doses of lifelong physical activity. One subject in group 2 had late gadolinium enhancement in a noncoronary distribution, and no subjects in groups 3 and 4 had evidence of late gadolinium enhancement.

Conclusions: A lifelong history of consistent physical activity, regardless of dose ranging from sedentary to competitive marathon running, was not associated with the development of focal myocardial fibrosis.

Citing Articles

Ventricular arrhythmias in association with athletic cardiac remodelling.

DAmbrosio P, Claessen G, Kistler P, Heidbuchel H, Kalman J, La Gerche A Europace. 2024; 26(12).

PMID: 39499658 PMC: 11641426. DOI: 10.1093/europace/euae279.


Efficacy and safety of ticagrelor monotherapy following a brief DAPT vs. prolonged 12-month DAPT in ACS patients post-PCI: a meta-analysis of RCTs.

Qamar U, Naeem F, Maqsood M, Khan M, Imtiaz Z, Saeed F Eur J Clin Pharmacol. 2024; 80(12):1871-1882.

PMID: 39264445 DOI: 10.1007/s00228-024-03747-w.


Myocardial Fibrosis in Young and Veteran Athletes: Evidence from a Systematic Review of the Current Literature.

Allwood R, Papadakis M, Androulakis E J Clin Med. 2024; 13(15).

PMID: 39124802 PMC: 11313657. DOI: 10.3390/jcm13154536.


Intrinsic and Extrinsic Contributors to the Cardiac Benefits of Exercise.

Hastings M, Castro C, Freeman R, Abdul Kadir A, Lerchenmuller C, Li H JACC Basic Transl Sci. 2024; 9(4):535-552.

PMID: 38680954 PMC: 11055208. DOI: 10.1016/j.jacbts.2023.07.011.


Low rates of myocardial fibrosis and ventricular arrhythmias in recreational athletes after SARS-CoV-2 infection.

Miljoen H, Favere K, Van De Heyning C, Corteville B, Dausin C, Herbots L Front Cardiovasc Med. 2024; 11:1372028.

PMID: 38628312 PMC: 11018940. DOI: 10.3389/fcvm.2024.1372028.


References
1.
Bohm P, Schneider G, Linneweber L, Rentzsch A, Kramer N, Abdul-Khaliq H . Right and Left Ventricular Function and Mass in Male Elite Master Athletes: A Controlled Contrast-Enhanced Cardiovascular Magnetic Resonance Study. Circulation. 2016; 133(20):1927-35. DOI: 10.1161/CIRCULATIONAHA.115.020975. View

2.
Turkbey E, Nacif M, Guo M, McClelland R, Teixeira P, Bild D . Prevalence and Correlates of Myocardial Scar in a US Cohort. JAMA. 2015; 314(18):1945-54. PMC: 4774246. DOI: 10.1001/jama.2015.14849. View

3.
Pelliccia A, Maron B, Spataro A, Proschan M, Spirito P . The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med. 1991; 324(5):295-301. DOI: 10.1056/NEJM199101313240504. View

4.
Trivax J, McCullough P . Phidippides cardiomyopathy: a review and case illustration. Clin Cardiol. 2012; 35(2):69-73. PMC: 6652719. DOI: 10.1002/clc.20994. View

5.
Fortescue E, Shin A, Greenes D, Mannix R, Agarwal S, Feldman B . Cardiac troponin increases among runners in the Boston Marathon. Ann Emerg Med. 2006; 49(2):137-43, 143.e1. DOI: 10.1016/j.annemergmed.2006.09.024. View